Case series:Adalimumab

2 trials

Sponsors

Zhongshan Ophthalmic Center, Sun Yat-sen University, Mianyang Hospital of Traditional Chinese Medicine

Conditions

Immune-Mediated Inflammatory Diseasesrefractory uveitis

Phase 4

Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammatory Diseases including rheumatoid arthritis, ankylosing spondylitis and psoriasis

RecruitingChiCTR2100044045

Mianyang Hospital of Traditional Chinese MedicineImmune-Mediated Inflammatory Diseases

Start: 2021-03-08Updated: 2021-07-21

Unknown Phase

Efficacy and Safety of Adalimumab in refractory uveitis

Active, not recruitingChiCTR2000030236

Zhongshan Ophthalmic Center, Sun Yat-sen Universityrefractory uveitis

Start: 2020-03-01Updated: 2020-03-02